Corton Capital’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $112K | Sell |
11,946
-5,085
| -30% | -$47.9K | 0.13% | 305 |
|
|
2025
Q1 | $92.3K | Sell |
17,031
-5,356
| -24% | -$29K | 0.31% | 135 |
|
|
2024
Q4 | $167K | Sell |
22,387
-7,257
| -24% | -$54.1K | 0.1% | 288 |
|
|
2024
Q3 | $237K | Sell |
29,644
-20,261
| -41% | -$162K | 0.12% | 292 |
|
|
2024
Q2 | $434K | Buy |
49,905
+38,126
| +324% | +$332K | 0.23% | 77 |
|
|
2024
Q1 | $243K | Buy |
11,779
+268
| +2% | +$5.54K | 0.09% | 348 |
|
|
2023
Q4 | $266K | Sell |
11,511
-11,171
| -49% | -$258K | 0.08% | 364 |
|
|
2023
Q3 | $181K | Buy |
+22,682
| New | +$181K | 0.09% | 328 |
|